Plant Health Care has announced that it has signed a long-term production and supply agreement with a leading European-based fermentation company. This secures low-cost production capacity of Harpin αβ, the active ingredient in its ProAct®, Employ®, and H2Copla® branded products, sufficient to meet projected global demand. Volume production cost targets have been met which should provide an improved gross margin for Plant Health Care and an attractive Return on Investment (ROI) for customers. Th ....
20 Jun 2022
Cenkos: Plant Health Care Plc -- Increased margins from new production
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Plant Health Care Plc -- Increased margins from new production
Plant Health Care PLC (PHC:LON) | 3.6 0 2.2% | Mkt Cap: 12.3m
- Published:
20 Jun 2022 -
Author:
John-Marc Bunce -
Pages:
6
Plant Health Care has announced that it has signed a long-term production and supply agreement with a leading European-based fermentation company. This secures low-cost production capacity of Harpin αβ, the active ingredient in its ProAct®, Employ®, and H2Copla® branded products, sufficient to meet projected global demand. Volume production cost targets have been met which should provide an improved gross margin for Plant Health Care and an attractive Return on Investment (ROI) for customers. Th ....